NCT06440525

A Study of RSLV-132 in Females With Sjögren's Disease

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2024-12-01Est. Completion: 2027-05-01

Enrollment target: 106 participants

Locations

Resolve Clinical Site, Chula Vista, California, United States
Resolve Clinical Site, Tustin, California, United States
Resolve Clinical Site, Boca Raton, Florida, United States
Resolve Clinical Site, Boynton Beach, Florida, United States
Evolution Research Center, Hialeah, Florida, United States
GNP Research, Hollywood, Florida, United States
Resolve Clinical Site, Miami, Florida, United States
Life Medical Research, Miami Gardens, Florida, United States
Resolve Clinical Site, Chicago, Illinois, United States
University of Iowa, Iowa City, Iowa, United States
Tufts College, Boston, Massachusetts, United States
Resolve Clinical Site, Albuquerque, New Mexico, United States
Joint and Muscle Research Institute, Charlotte, North Carolina, United States
Arthritis and Osteoporosis Consultants of the Carolinas, Charlotte, North Carolina, United States
Onsite Clinical Solutions, Salisbury, North Carolina, United States
Altoona Center for Clinical Research, Duncansville, Pennsylvania, United States

Primary Sjögren SyndromeSarcopenia

The aim of this study is to evaluate the frequency of probable sarcopenia and sarcopenia in patients with primary Sjögre…

Antalya, Turkey (Türkiye)Est. completion Jul 20, 2025

Sjogren Syndrome

Sjögren disease (SjD) is a chronic autoimmune disease in which salivary gland dysfunction commonly causes persistent dry…

Multiple LocationsEst. completion Jun 30, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.